Clinical efficacy of nab-paclitaxel in patients with metastatic pancreatic cancer

PURPOSE: Pancreatic carcinoma is the neoplasia with the major mortality, and main standard treatments in this cancer increase survival but do not lead to complete recovery of the patient. The aim of this study was to evaluate the efficacy of Abraxane(®) (nab-paclitaxel) in Italian patients with meta...

Descripción completa

Detalles Bibliográficos
Autores principales: De Luca, Rossella, Blasi, Livio, Alù, Massimiliano, Gristina, Valerio, Cicero, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016012/
https://www.ncbi.nlm.nih.gov/pubmed/29950811
http://dx.doi.org/10.2147/DDDT.S165851

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6016012/
https://www.ncbi.nlm.nih.gov/pubmed/29950811
http://dx.doi.org/10.2147/DDDT.S165851

Ejemplares similares